CXCR2 and neoplasm: Increased CXCR2 expression in tumor cells supports cell survival, epithelial-mesenchymal transition, and recruitment of myeloid-derived suppressor cells (MDSC) to the tumor microenvironment, which promote tumor progression and protect tumors from the body’s natural antitumor immune response [1, 3, 7, 8].